Kevin Douglas has deep experience representing public companies on corporate and securities laws related matters, including companies within the healthcare industry. Kevin’s public company practice focuses on corporate governance matters, securities laws compliance, mergers and acquisitions, corporate finance and shareholder activism. His representative experience has ranged from providing SEC disclosure advice to the audit committee of a Fortune 100 company to representing an NYSE-listed company in connection with its $4.3 billion acquisition by another public company to representing another NYSE-listed company in connection with its issuance of $2.2 billion in senior notes. Kevin has also represented private companies in a wide variety of mergers and acquisition, corporate finance, and other corporate law matters. Kevin served as chair of the Corporate & Securities Practice Group from 2018-2021.
Kevin H. Douglas
Member
Nashville
Notice
Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.
Kevin H. Douglas
Member
Nashville
kdouglas@bassberry.com
https://www.bassberry.com/professionals/douglas-kevin-h/
Featured Experience
-
We were engaged in 2010 to serve as independent disclosure counsel to the Audit Committee of the Board of Directors...
Memberships
American Bar Association
American Health Law Association (AHLA)
Kevin Douglas has deep experience representing public companies on corporate and securities laws related matters, including companies within the healthcare industry. Kevin’s public company practice focuses on corporate governance matters, securities laws compliance, mergers and acquisitions, corporate finance and shareholder activism. His representative experience has ranged from providing SEC disclosure advice to the audit committee of a Fortune 100 company to representing an NYSE-listed company in connection with its $4.3 billion acquisition by another public company to representing another NYSE-listed company in connection with its issuance of $2.2 billion in senior notes. Kevin has also represented private companies in a wide variety of mergers and acquisition, corporate finance, and other corporate law matters. Kevin served as chair of the Corporate & Securities Practice Group from 2018-2021.
Memberships
American Bar Association
American Health Law Association (AHLA)
Representative Experience
-
We were engaged in 2010 to serve as independent disclosure counsel to the Audit Committee of the Board of Directors...
-
Represented Reinsurance Group of America, Incorporated in its $400,000,000 public offering of 6.000% senior notes due 2033.
-
We represent Lirio, an artificial intelligence platform that drives better health outcomes through person-centered communication, in the drafting and negotiation of various IP and technology-related contracts, including customer agreements, digital services agreements, and licensing agreements.
-
We represented Dean Solon, the founder of Shoals Technologies Group, Inc. (backed by Oaktree Capital), a leading solar-power components maker, in connection with Shoals’ initial public offering (IPO) of 88.5 million shares of Class A common stock for a total net proceeds of more than $2.2 billion. The shares began trading on the Nasdaq Global Market under the symbol “SHLS” on January 27, 2021. Bass Berry & Sims has represented Shoals since the 2016 recapitalization transaction with Oaktree Capital.
-
We represented HealthStream (Nasdaq: HSTM), a leading provider of workforce and provider solutions for the healthcare industry, in its $67.5 million cash acquisition of Change Healthcare’s staff scheduling business, which includes ANSOS™ Staff Scheduling application and related products. Together, ANSOS with recent acquisitions, ShiftWizard and NurseGrid, will represent HealthStream’s portfolio of nurse and staff scheduling solutions and helps establish them as the market leader in healthcare workforce scheduling business.
-
Representation of Forcura, LLC, a healthcare technology that facilitates continuity of care, in its sale to Accel-KKR, a Silicon Valley-based technology-focused private equity firm
-
Represented Addus HomeCare Corporation (Nasdaq: ADUS) in four strategic acquisitions and in its underwritten public offering of 2.3 million shares of common stock in 2019.
-
Represented Pace Payment Systems, Inc. in its sale to i3 Verticals, Inc. for $52.7 million
-
Represented Engility Holdings in its merger with Science Applications International Corp. in which SAIC acquired Engility in an all-stock transaction valued at $2.5 billion
-
Representation of Change Healthcare in its strategic investment for a minority position in MDsave, a technology and healthcare payments company that simplifies the healthcare services shopping and payment experience for consumers
-
Addus Homecare August 2018 Common Stock Offering
Representative Experience
-
Client Type: Public Company
-
Client Type: Public Company
-
Client Type: Private Company
-
Client Type: Public Company
-
Client Type: Public Company
-
Client Type: Private Company
-
Client Type: Public Company
-
Client Type: Private Company
-
Client Type: Public Company
-
Client Type: Private Company
-
Client Type: Public Company
Publications
-
March 7, 2024 | Securities Law Exchange Blog
-
October 23, 2023 | Firm Publication
-
January 3, 2024 | Securities Law Exchange Blog
Past Events
-
December 12, 2023 | WebinarBass, Berry & Sims
-
May 11, 2023 | Bass, Berry & SimsSociety for Corporate Governance
-
February 2, 2023 | WebinarBass, Berry & Sims
Media Mentions & Firm News
-
August 17, 2023 | Best Lawyers®
-
August 18, 2022 | The Best Lawyers in America ©
-
August 27, 2021 | IFLR1000 2021
Publications
-
March 7, 2024 | Securities Law Exchange Blog
-
October 23, 2023 | Firm Publication
-
January 3, 2024 | Securities Law Exchange Blog
Media Mentions & Firm News
-
August 17, 2023 | Best Lawyers®
-
August 18, 2022 | The Best Lawyers in America ©
-
August 27, 2021 | IFLR1000 2021
Accolades
The Best Lawyers in America© — Corporate Law (2013-2024)
IFLR1000 — Notable Practitioner (2019-2021)
Vanderbilt Law Review — Member (1996-1998)
Accolades
The Best Lawyers in America© — Corporate Law (2013-2024)
IFLR1000 — Notable Practitioner (2019-2021)
Vanderbilt Law Review — Member (1996-1998)
Related Services
Related Industries
-
Vanderbilt Law School - J.D., 1998
Order of the Coif
-
University of Virginia - B.A., 1995
Education
-
Vanderbilt Law School - J.D., 1998
Order of the Coif
-
University of Virginia - B.A., 1995
-
District of Columbia, 2000
-
Tennessee, 1998
Admissions
-
District of Columbia, 2000
-
Tennessee, 1998